Summary
The present investigation was undertaken to determine and characterize glucagon immunoreactivity in plasma from normal NMRI mice and from dystrophic mice and their unaffected littermates of the 129/ReJ strain. Very young dystrophic mice (6 weeks old) displayed much higher basal levels of plasma glucagon immunoreactivity than normal mice. In contrast, plasma concentrations of insulin and glucose were lower in these dystrophic mice than in normal NMRI mice. The plasma glucagon levels declined with age in both strains during the time-period studied (1.5–5 months). Gel filtration of plasma from dystrophic as well as normal mice on Sephadex G-200 revealed that a large part of the total glucagon immunoreactivity was eluted in fractions containing the immunoglobulins. The amount of the ‘true’ glucagon part was lower in plasma from normal mice (about 0.2 μg/l) than in plasma from mice of the dystrophic strain (0.4–0.5 μg/l)). This finding was indirectly corroborated by the observation that a large intravenous glucose load decreased plasma glucagon by approximately 0.2 μg/l in the non-dystrophic NMRI strain and by about 0.4–0.6 μg/l in the dystrophic strain. Thus, the ability of glucose to suppress glucagon secretion appeared unaffected in the dystrophic mice. Glucose-induced insulin release, however, was considerably impaired in these animals. It is concluded that mice of the dystrophic 129/ReJ strain have higher plasma levels of ‘true’ glucagon than mice of the non-dystrophic NMRI strain. Whether the abnormally high plasma glucagon levels in the dystrophic strain, particularly in very young dystrophic mice, might contribute to the development of the muscular dystrophy remains to be elucidated.
Article PDF
Similar content being viewed by others
References
Unger RH, Eisentraut AM, McCall MS, Keller S, Lanz H-C, Madison LL (1959) Glucagon antibodies and their use for immunoassay for glucagon. Proc Soc Exp Biol Med 102: 621–623
Eisentraut A, Ohneda A, Panada E, Unger RH (1968) Immunologic discrimination between pancreatic glucagon and enteric glucagon-like immunoreactivity (GLI) in tissue and plasma. Diabetes 17: 321–322
Heding LG (1971) Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7: 10–19
Alford EP, Bloom SR, Nabarro JDN (1977) Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay. Diabetologia 13: 1–6
Holst JJ, Aasted B (1974) Production and evaluation of glucagon antibodies for radioimmunoassay. Acta Endocrinol (Copenh) 77: 715–726
von Schenk H (1977) Production and characterization of an antiserum against pancreatic glucagon. Clin Chim Acta 80: 455–463
Weir G (1977) Assessment of glucagon immunoreactivity in plasma. In: Foà PP, Bajaj JS, Foà NL (eds) Glucagon: its role in physiology and clinical medicine, Springer-Verlag, New York Heidelberg Berlin pp 65–76.
Cuendet GS, Loten EG, Cameron DP, Renold AE, Marliss EB (1975) Hormone-substrate responses to total fasting in lean and obese mice. Am J Physiol 228: 276–283
Lavine RL, Voyles N, Perrino PV, Recant L (1975) The effect of fasting on tissue cyclic AMP and plasma glucagon in the obese hyperglycemic mouse. Endocrinology 97: 615–620
Lundquist I, Håkanson R, Harris JB, Libelius R, Sundler F (1979) Endocrine pancreas in the dystrophic mouse. Ann NY Acad Sci 317: 206–220
Lundquist I, Harris JB (1979) Insulin secretion and carbohydrate metabolism in the dystrophic mouse. Europ J Pharmacol 53: 365–373
Heding L (1966) A simplified insulin radioimmunoassay method. In: Donato L, Milhaud G, Sirchis J (eds) Labelled proteins in tracer studies. Euratom, Brussel pp 345–350
Bruss ML, Black AL (1978) Enzymatic microdetermination of glycogen. Anal Biochem 84: 309–312
Rerup C, Lundquist I (1966) Blood glucose level in mice I. Evaluation of a new technique of multiple serial sampling. Acta Endocrinol (Copenh) 52: 357–367
Valverde I, Villanueva ML, Lozano I, Marco J (1974) Presence of glucagon immunoreactivity in the globulin fraction of human plasma (“big plasma glucagon”). J Clin Endocrinol Metab 39: 1090–1098
Weir GC, Knowlton SD, Martin DB (1975) High molecular weight glucagon-like immunoreactivity in plasma. J Clin Endocrinol Metab 40: 296–302
Rehfeld JF, Schwartz TW, Stadil F (1977) Immunochemical studies on macromolecular gastrins. Evidence that “big big gastrins” are artifacts in blood and mucosa but truly present in some large gastrinomas. Gastroenterology 73: 469–477
Sanders BG, Kline K(1977) IgG immunoglobulin deficiency in muscular dystrophic chickens. J Heredity 68: 55–56
Unger RH, Orci L (1976) Physiology and pathophysiology of glucagon. Physiol Rev 56: 779–826
Grodsky GM, Fanska R, Lundquist I (1975) Interrelationships between α and β-anomers of glucose affecting both insulin and glucagon secretion in the perfused rat pancreas. Endocrinology 97: 573–580
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahrén, B., Lundquist, I. Glucagon immunoreactivity in plasma from normal and dystrophic mice. Diabetologia 22, 258–263 (1982). https://doi.org/10.1007/BF00281302
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00281302